TY  - JOUR
AU  - Viggiano, Davide
AU  - Bruchfeld, Annette
AU  - Carriazo, Sol
AU  - de Donato, Antonio
AU  - Endlich, Nicole
AU  - Ferreira, Ana Carina
AU  - Figurek, Andreja
AU  - Fouque, Denis
AU  - Franssen, Casper F.M.
AU  - Giannakou, Konstantinos
AU  - Goumenos, Dimitrios
AU  - Hoorn, Ewout J.
AU  - Nitsch, Dorothea
AU  - Ortiz, Alberto
AU  - Pešić, Vesna
AU  - Rastenyté, Daiva
AU  - Soler, Maria José
AU  - Rroji, Merita
AU  - Trepiccione, Francesco
AU  - Unwin, Robert J.
AU  - Wagner, Carsten A.
AU  - Wieçek, Andrzej
AU  - Zacchia, Miriam
AU  - Zoccali, Carmine
AU  - Capasso, Giovambattista
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4030
AB  - Kidney function has two important elements: glomerular filtration and tubular function (secretion and reabsorption). A persistent decrease in glomerular filtration rate (GFR), with or without proteinuria, is diagnostic of chronic kidney disease (CKD). While glomerular injury or disease is a major cause of CKD and usually associated with proteinuria, predominant tubular injury, with or without tubulointerstitial disease, is typically non-proteinuric. CKD has been linked with cognitive impairment, but it is unclear how much this depends on a decreased GFR, altered tubular function or the presence of proteinuria. Since CKD is often accompanied by tubular and interstitial dysfunction, we explore here for the first time the potential role of the tubular and tubulointerstitial compartments in cognitive dysfunction. To help address this issue we selected a group of primary tubular diseases with preserved GFR in which to review the evidence for any association with brain dysfunction. Cognition, mood, neurosensory and motor disturbances are not well characterized in tubular diseases, possibly because they are subclinical and less prominent than other clinical manifestations. The available literature suggests that brain dysfunction in tubular and tubulointerstitial diseases is usually mild and is more often seen in disorders of water handling. Brain dysfunction may occur when severe electrolyte and water disorders in young children persist over a long period of time before the diagnosis is made. We have chosen Bartter and Gitelman syndromes and nephrogenic diabetes insipidus as examples to highlight this topic. We discuss current published findings, some unanswered questions and propose topics for future research.
PB  - Oxford University Press
T2  - Nephrology Dialysis Transplantation
T1  - Brain dysfunction in tubular and tubulointerstitial kidney diseases
VL  - 37
IS  - supplement 2
SP  - ii46
EP  - ii55
DO  - 10.1093/ndt/gfab276
ER  - 

@article{
author = "Viggiano, Davide and Bruchfeld, Annette and Carriazo, Sol and de Donato, Antonio and Endlich, Nicole and Ferreira, Ana Carina and Figurek, Andreja and Fouque, Denis and Franssen, Casper F.M. and Giannakou, Konstantinos and Goumenos, Dimitrios and Hoorn, Ewout J. and Nitsch, Dorothea and Ortiz, Alberto and Pešić, Vesna and Rastenyté, Daiva and Soler, Maria José and Rroji, Merita and Trepiccione, Francesco and Unwin, Robert J. and Wagner, Carsten A. and Wieçek, Andrzej and Zacchia, Miriam and Zoccali, Carmine and Capasso, Giovambattista",
year = "2022",
abstract = "Kidney function has two important elements: glomerular filtration and tubular function (secretion and reabsorption). A persistent decrease in glomerular filtration rate (GFR), with or without proteinuria, is diagnostic of chronic kidney disease (CKD). While glomerular injury or disease is a major cause of CKD and usually associated with proteinuria, predominant tubular injury, with or without tubulointerstitial disease, is typically non-proteinuric. CKD has been linked with cognitive impairment, but it is unclear how much this depends on a decreased GFR, altered tubular function or the presence of proteinuria. Since CKD is often accompanied by tubular and interstitial dysfunction, we explore here for the first time the potential role of the tubular and tubulointerstitial compartments in cognitive dysfunction. To help address this issue we selected a group of primary tubular diseases with preserved GFR in which to review the evidence for any association with brain dysfunction. Cognition, mood, neurosensory and motor disturbances are not well characterized in tubular diseases, possibly because they are subclinical and less prominent than other clinical manifestations. The available literature suggests that brain dysfunction in tubular and tubulointerstitial diseases is usually mild and is more often seen in disorders of water handling. Brain dysfunction may occur when severe electrolyte and water disorders in young children persist over a long period of time before the diagnosis is made. We have chosen Bartter and Gitelman syndromes and nephrogenic diabetes insipidus as examples to highlight this topic. We discuss current published findings, some unanswered questions and propose topics for future research.",
publisher = "Oxford University Press",
journal = "Nephrology Dialysis Transplantation",
title = "Brain dysfunction in tubular and tubulointerstitial kidney diseases",
volume = "37",
number = "supplement 2",
pages = "ii46-ii55",
doi = "10.1093/ndt/gfab276"
}

Viggiano, D., Bruchfeld, A., Carriazo, S., de Donato, A., Endlich, N., Ferreira, A. C., Figurek, A., Fouque, D., Franssen, C. F.M., Giannakou, K., Goumenos, D., Hoorn, E. J., Nitsch, D., Ortiz, A., Pešić, V., Rastenyté, D., Soler, M. J., Rroji, M., Trepiccione, F., Unwin, R. J., Wagner, C. A., Wieçek, A., Zacchia, M., Zoccali, C.,& Capasso, G.. (2022). Brain dysfunction in tubular and tubulointerstitial kidney diseases. in Nephrology Dialysis Transplantation
Oxford University Press., 37(supplement 2), ii46-ii55.
https://doi.org/10.1093/ndt/gfab276

Viggiano D, Bruchfeld A, Carriazo S, de Donato A, Endlich N, Ferreira AC, Figurek A, Fouque D, Franssen CF, Giannakou K, Goumenos D, Hoorn EJ, Nitsch D, Ortiz A, Pešić V, Rastenyté D, Soler MJ, Rroji M, Trepiccione F, Unwin RJ, Wagner CA, Wieçek A, Zacchia M, Zoccali C, Capasso G. Brain dysfunction in tubular and tubulointerstitial kidney diseases. in Nephrology Dialysis Transplantation. 2022;37(supplement 2):ii46-ii55.
doi:10.1093/ndt/gfab276 .

Viggiano, Davide, Bruchfeld, Annette, Carriazo, Sol, de Donato, Antonio, Endlich, Nicole, Ferreira, Ana Carina, Figurek, Andreja, Fouque, Denis, Franssen, Casper F.M., Giannakou, Konstantinos, Goumenos, Dimitrios, Hoorn, Ewout J., Nitsch, Dorothea, Ortiz, Alberto, Pešić, Vesna, Rastenyté, Daiva, Soler, Maria José, Rroji, Merita, Trepiccione, Francesco, Unwin, Robert J., Wagner, Carsten A., Wieçek, Andrzej, Zacchia, Miriam, Zoccali, Carmine, Capasso, Giovambattista, "Brain dysfunction in tubular and tubulointerstitial kidney diseases" in Nephrology Dialysis Transplantation, 37, no. supplement 2 (2022):ii46-ii55,
https://doi.org/10.1093/ndt/gfab276 . .

TY  - JOUR
AU  - Liabeuf, Sophie
AU  - Pepin, , Marion
AU  - Franssen, Casper F.M.
AU  - Viggiano, Davide
AU  - Carriazo, Sol
AU  - Gansevoort, Ron T.
AU  - Gesualdo, Loreto
AU  - Hafez, Gaye
AU  - Malyszko, Jolanta
AU  - Mayer, Christopher
AU  - Nitsch, Dorothea
AU  - Ortiz, Alberto
AU  - Pešić, Vesna
AU  - Wiecek, Andrzej
AU  - Massy, Ziad
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4029
AB  - Chronic kidney disease (CKD) perturbs the crosstalk with others organs, with the interaction between the kidneys and the heart having been studied most intensively. However, a growing body of data indicates that there is an association between kidney dysfunction and disorders of the central nervous system. In epidemiological studies, CKD is associated with a high prevalence of neurological complications, such as cerebrovascular disorders, movement disorders, cognitive impairment and depression. Along with traditional cardiovascular risk factors (such as diabetes, inflammation, hypertension and dyslipidaemia), non-traditional risk factors related to kidney damage (such as uraemic toxins) may predispose patients with CKD to neurological disorders. There is increasing evidence to show that uraemic toxins, for example indoxyl sulphate, have a neurotoxic effect. A better understanding of factors responsible for the elevated prevalence of neurological disorders among patients with CKD might facilitate the development of novel treatments. Here, we review (i) the potential clinical impact of CKD on cerebrovascular and neurological complications, (ii) the mechanisms underlying the uraemic toxins' putative action (based on pre-clinical and clinical research) and (iii) the potential impact of these findings on patient care.
PB  - Oxford University Press
T2  - Nephrology Dialysis Transplantation
T1  - Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?
VL  - 37
IS  - supplement 2
SP  - ii33
EP  - ii44
DO  - 10.1093/ndt/gfab223
ER  - 

@article{
author = "Liabeuf, Sophie and Pepin, , Marion and Franssen, Casper F.M. and Viggiano, Davide and Carriazo, Sol and Gansevoort, Ron T. and Gesualdo, Loreto and Hafez, Gaye and Malyszko, Jolanta and Mayer, Christopher and Nitsch, Dorothea and Ortiz, Alberto and Pešić, Vesna and Wiecek, Andrzej and Massy, Ziad",
year = "2022",
abstract = "Chronic kidney disease (CKD) perturbs the crosstalk with others organs, with the interaction between the kidneys and the heart having been studied most intensively. However, a growing body of data indicates that there is an association between kidney dysfunction and disorders of the central nervous system. In epidemiological studies, CKD is associated with a high prevalence of neurological complications, such as cerebrovascular disorders, movement disorders, cognitive impairment and depression. Along with traditional cardiovascular risk factors (such as diabetes, inflammation, hypertension and dyslipidaemia), non-traditional risk factors related to kidney damage (such as uraemic toxins) may predispose patients with CKD to neurological disorders. There is increasing evidence to show that uraemic toxins, for example indoxyl sulphate, have a neurotoxic effect. A better understanding of factors responsible for the elevated prevalence of neurological disorders among patients with CKD might facilitate the development of novel treatments. Here, we review (i) the potential clinical impact of CKD on cerebrovascular and neurological complications, (ii) the mechanisms underlying the uraemic toxins' putative action (based on pre-clinical and clinical research) and (iii) the potential impact of these findings on patient care.",
publisher = "Oxford University Press",
journal = "Nephrology Dialysis Transplantation",
title = "Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?",
volume = "37",
number = "supplement 2",
pages = "ii33-ii44",
doi = "10.1093/ndt/gfab223"
}

Liabeuf, S., Pepin, ,. M., Franssen, C. F.M., Viggiano, D., Carriazo, S., Gansevoort, R. T., Gesualdo, L., Hafez, G., Malyszko, J., Mayer, C., Nitsch, D., Ortiz, A., Pešić, V., Wiecek, A.,& Massy, Z.. (2022). Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?. in Nephrology Dialysis Transplantation
Oxford University Press., 37(supplement 2), ii33-ii44.
https://doi.org/10.1093/ndt/gfab223

Liabeuf S, Pepin ,M, Franssen CF, Viggiano D, Carriazo S, Gansevoort RT, Gesualdo L, Hafez G, Malyszko J, Mayer C, Nitsch D, Ortiz A, Pešić V, Wiecek A, Massy Z. Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?. in Nephrology Dialysis Transplantation. 2022;37(supplement 2):ii33-ii44.
doi:10.1093/ndt/gfab223 .

Liabeuf, Sophie, Pepin, , Marion, Franssen, Casper F.M., Viggiano, Davide, Carriazo, Sol, Gansevoort, Ron T., Gesualdo, Loreto, Hafez, Gaye, Malyszko, Jolanta, Mayer, Christopher, Nitsch, Dorothea, Ortiz, Alberto, Pešić, Vesna, Wiecek, Andrzej, Massy, Ziad, "Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?" in Nephrology Dialysis Transplantation, 37, no. supplement 2 (2022):ii33-ii44,
https://doi.org/10.1093/ndt/gfab223 . .